Showing results (1-10 of 45) with videos related to
Sort By:
Pageof 5
Current Hematologic Malignancy Reports|April 29, 2010
Prognosis in myelodysplastic syndromes: are the new classifications useful?Naomi Galili, Azra RazaBest Practice & Research. Clinical Haematology|August 25, 2009
Clinical implications of gene expression profiling in myelodysplastic syndromes: recognition of ribosomal and translational gene dysregulation and development of predictive assaysNaomi Galili, Azra RazaNature Reviews. Cancer|November 24, 2012
The genetic basis of phenotypic heterogeneity in myelodysplastic syndromesAzra Raza, Naomi GaliliExpert Opinion on Investigational Drugs|June 22, 2006
Immunomodulatory drugs in myelodysplastic syndromesNaomi Galili, Azra RazaExpert Opinion on Pharmacotherapy|May 22, 2010
Pharmacotherapy of myelodysplastic syndromesNaomi Galili, Azra RazaBlood Reviews|December 6, 2011
MDS: Refining existing therapy through improved biologic insightsJordan Schecter, Naomi Galili, Azra RazaCurrent Treatment Options in Oncology|July 20, 2007
Current treatment options: impact of cytogenetics on the course of myelodysplasiaNaomi Galili, Jan Cerny, Azra RazaJournal of Hematology & Oncology|July 12, 2008
Isolation of specific and biologically active peptides that bind cells from patients with acute myeloid leukemia (AML)Naomi Galili, Emmanuelle Devemy, Azra RazaHematology Reports|December 21, 2011
The biology of myelodysplastic syndromes: unity despite heterogeneityAzra Raza, Raymond Cruz, Tahir Latif, et al.Reviews in Clinical and Experimental Hematology|July 20, 2005
Translational research in myelodysplastic syndromesAzra Raza, Huma Qawi, Murtaza Mehdi, et al.Pageof 5